Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

The Genomic and Transcriptomic Landscape of Double-Refractory Multiple Myeloma

Bachisio Ziccheddu, PhD, Giulia Biancon, Chiara De Philippis, MD, Filippo Bagnoli, MD, Francesco Maura, MD, Matteo Dugo, Andrea Devecchi, Loris De Cecco, Marialuisa Sensi, Carolina Terragna, Marina Martello, Tina Bagratuni, PhD, Eftathios Kastritis, Meletios A. Dimopoulos, MD, Michele Cavo, Cristiana Carniti, PhD, Vittorio Montefusco, Paolo Corradini, Niccolo Bolli, MD PhD

Blood (2019) 134 (Supplement_1): 3056.

https://doi.org/10.1182/blood-2019-122197

Published: 2019

Journal Articles

Timing the Initiation of Multiple Myeloma

Blood (2019) 134 (Supplement_1): 573.

https://doi.org/10.1182/blood-2019-124357

Published: 2019

Journal Articles

Dose-Adjusted EPOCH and Rituximab (DA-EPOCH-R) Treatment in Dual Expressor Diffuse Large B-Cell and Double/Triple Hit Lymphomas: TP53 Mutations Influence on Clinical Outcome

Anna Dodero, MD, Anna Guidetti, MD, Fabrizio Marino, MD, Cristiana Carniti, PhD, Stefania Banfi, Alessandra Tucci, MD, Monica Balzarotti, Antonello Domenico Cabras, MD, Valentina Monti, PhD, Liliana Franca Devizzi, MD, Lucia Farina, MD, Maria Chiara Di Chio, MD, Giuseppe Rossi, Carmelo Carlo-Stella, MD, Paolo Corradini

Blood (2019) 134 (Supplement_1): 4116.

https://doi.org/10.1182/blood-2019-124350

Published: 2019

Journal Articles

The Real Life Accessibility to CAR T-Cell Therapy: Current Experience in the Only Active Center in Italy

Anna Guidetti, MD, Giulia Perrone, MD, Paola Coluccia, MD, Luca Fumagalli, MD, Anna Dodero, MD, Lucia Farina, MD, Flavio Arienti, MD, Filippo Bagnoli, MD, Luca Pappalettera, MD, Debora Degli Innocenti, Cristiana Carniti, PhD, Daniela Codazzi, MD, Paolo Corradini

Blood (2019) 134 (Supplement_1): 5619.

https://doi.org/10.1182/blood-2019-125286

Published: 2019

Journal Articles

Role of Cell Source and Graft Composition in Haploidentical Transplantation Using Post-Transplant Cyclophosphamide

Alberto Mussetti, MD, Chiara De Philippis, MD, Cristiana Carniti, PhD, Mariana Bastos Oreiro, MD, Jorge Gayoso, MD, Nicoletta Cieri, MD PhD, Jacopo Peccatori, MD, Paolo Corradini, MD

Blood (2016) 128 (22): 4664.

https://doi.org/10.1182/blood.V128.22.4664.4664

Published: 2016

Journal Articles

GATA-3 Expression in Peripheral T-Cell Lymphomas (PTCL): Identification of a Cut-Off and Prognostic Value in PTCL-NOS Versus Others Hystotypes

Anna Dodero, MD, Francesco Maura, MD, Alessio Pellegrinelli, MD, Antonello Cabras, MD, Annalisa Chiappella, MD, Domenico Novero, MD, Federico Vittone, MD, Francesco Zaja, MD, Stefano Pizzolitto, MD, Cristiana Carniti, PhD, Alessandra Cavane', Martina Pennisi, MD, Umberto Vitolo, MD, Niccolo' Bolli, MD, Paolo Corradini

Blood (2015) 126 (23): 3889.

https://doi.org/10.1182/blood.V126.23.3889.3889

Published: 2015

Journal Articles

High Dose Chemotherapy with Autograft in First Relapse May Overcome the Poor Prognosis of Diffuse Large B-Cell Lymphoma Patients with MYC/BCL2 Co-Expression

Francesco Maura, MD, Anna Dodero, Alessio Pellegrinelli, MD, Martina Pennisi, Liliana Franca Devizzi, Anna Guidetti, MD, Cristiana Carniti, PhD, Lucia Farina, MD PhD, Antonello Cabras, MD, Paolo Corradini

Blood (2015) 126 (23): 1976.

https://doi.org/10.1182/blood.V126.23.1976.1976

Published: 2015

Journal Articles

Inhibition of Jak1/Jak2 Is More Effective Than Inhibition of Jak3 in Protecting Mice From Acute Graft-Versus-Host Disease (aGvHD) by Significantly Decreasing Alloreactive CD4+ T-Cells.

Cristiana Carniti, PhD, Silvia Gimondi, Raffaella Vaccaroli, Antonio Vendramin, PhD, Anisa Bermema, Enrico Radaelli, DVM, PhD, Jacopo Mariotti, MD, Paolo Corradini, MD

Blood (2012) 120 (21): 2997.

https://doi.org/10.1182/blood.V120.21.2997.2997

Published: 2012

Journal Articles

Evaluation of MRD Status by Flow Cytometry and PCR in Multiple Myeloma Elderly Patients Receiving Autologous Stem Cell Transplantation After Bortezomib-Supplemented Mobilization and Conditioning

Immacolata Attolico, Roberta Nuccorini, Alberto Fragasso, Vincenzo Pavone, Pellegrino Musto, Silvana Capalbo, MD, Gaetano Palumbo, MD, Giorgina Specchia, Cristiana Carniti, PhD, Paolo Corradini, MD, Sara Pascale, Sabrina Coluzzi, Michele Pizzuti, Angela Amendola, Michele Cimminiello, Angela Matturro, Domenico Vertone, Nunzio Filardi, Attilio Olivieri, MD

Blood (2012) 120 (21): 4523.

https://doi.org/10.1182/blood.V120.21.4523.4523

Published: 2012

Journal Articles

G-CSF Stem Cell Mobilization Is Protective Against Acute Graft-Versus-Host Disease (aGvHD) by Increasing Myeloid-Derived Suppressor Cell (MDSC) Frequencies

Cristiana Carniti, PhD, Antonio Vendramin, PhD, Silvia Gimondi, Anisa Bermema, Fabiana Riva, Jacopo Mariotti, MD, Paolo Corradini, MD

Blood (2012) 120 (21): 1898.

https://doi.org/10.1182/blood.V120.21.1898.1898

Published: 2012

Journal Articles

High-Dose Rituximab in the Conditioning Regimen Before Allogeneic Stem Cell Transplantation Reduces the Incidence of Acute Gvhd in B-Cell Lymphomas

Paolo Corradini, Barbara Sarina, MD, Cristiana Carniti, PhD, Francesca Patriarca, MD, Angelo Michele Carella, MD, Alessandro Levis, Alberto Bosi, MD, Michele Falda, Paolo Di Bartolomeo, MD, Cecilia Olivares, MD, Silvia Gimondi, Antonio Vendramin, Anna Dodero, MD

Blood (2011) 118 (21): 4546.

https://doi.org/10.1182/blood.V118.21.4546.4546

Published: 2011

Journal Articles

Noninvasive Prediction of Acute Graft-Verus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation by Circulating miRNA Profiling

Cristiana Carniti, PhD, Silvia Gimondi, Davide Lucini, Jacopo Mariotti, MD, Anisa Bermema, Antonio Vendramin, Mara Morelli, MD, Chiara Formica, Paolo Corradini, MD

Blood (2011) 118 (21): 311.

https://doi.org/10.1182/blood.V118.21.311.311

Published: 2011

Journal Articles

Analysis of Circulating Microrna Expression Profile In Patients Transplanted From Matched Unrelated Donors (MUD) Identifies mir203 as a Putative Marker of aGVHD

Cristiana Carniti, PhD, Silvia A Gimondi, Anisa Bermema, Antonio Vendramin, Mara Morelli, Paolo Corradini, MD

Blood (2010) 116 (21): 2308.

https://doi.org/10.1182/blood.V116.21.2308.2308

Published: 2010

Journal Articles

Impact of Minor Histocompatibility Antigens (mHAg) Mismatches On Gvhd Incidence in Non-Myeloablative or Reduced Intensity Allogeneic Stem Cell Transplantation.

Cristiana Carniti, PhD, Francesco Spina, MD, Antonio Vendramin, PhD, Simona Di Terlizzi, Anna Raganato, PhD, Anisa Bermema, Paolo Corradini, MD

Blood (2009) 114 (22): 4494.

https://doi.org/10.1182/blood.V114.22.4494.4494

Published: 2009

Journal Articles

Donor Lymphocyte Infusions and Rituximab Are An Effective Treatment Strategy for B-Cell Lymphoma Relapsing After Reduced Intensity Allogeneic Stem Cell Transplantation.

Francesco Spina, MD, Francesca Patriarca, MD, Lucia Farina, MD, PhD, Vittorio Montefusco, MD, Anna Dodero, MD, Cristiana Carniti, PhD, Renato Fanin, MD, Paolo Corradini, MD

Blood (2009) 114 (22): 3310.

https://doi.org/10.1182/blood.V114.22.3310.3310

Published: 2009

Journal Articles

CD8-Depleted Donor Lymphocyte Infusions Can Improve Both T- and B-Cell Reconstitution after Allogeneic Stem Cell Transplantation from Haploidentical Family Donors

Anna Dodero, MD, Cristiana Carniti, PhD, Anna Raganato, PhD, Antonio Vendramin, PhD, Simona Di Terlizzi, PhD, Lucia Farina, MD, Francesco Spina, MD, Franca Fossati Bellani, MD, Marco Milanesi, PhD, Paolo Longoni, PhD, Lorenza Gandola, MD, Claudia Lombardo, MD, Paolo Corradini, MD

Blood (2008) 112 (11): 354.

https://doi.org/10.1182/blood.V112.11.354.354

Published: 2008

Journal Articles

Long-Term Follow-up of Patients Affected by Relapsed Lymphomas Receiving Reduced-Intensity Conditioning (RIC) Regimen Followed by Allogeneic Stem Cell Transplantation (Allo-SCT): An Update of the Phase II Study of the Gruppo Italiano Trapianto Di Midollo Osseo (GITMO)

Blood (2008) 112 (11): 3303.

https://doi.org/10.1182/blood.V112.11.3303.3303

Published: 2008

Journal Articles

Qualitative and Quantitative PCR Monitoring of MRD: Practical Implications of a Surrogate Marker for GVL Effect after RIC Allogeneic Transplantation in Relapsed Chronic Lymphocytic Leukemia.

Lucia Farina, MD, Cristiana Carniti, PhD, Anna Dodero, MD, Antonio Vendramin, Anna Raganato, Bsc, Francesca Patriarca, MD, Franco Narni, MD, Vittorio Montefusco, MD, Fabio Benedetti, MD, Attilio Olivieri, MD, Paolo Corradini, MD

Blood (2007) 110 (11): 1659.

https://doi.org/10.1182/blood.V110.11.1659.1659

Published: 2007

Journal Articles

Telomere Length of Hematopoietic Cells Following Autologous and Allogeneic Stem Cell Transplant (SCT) Reflects That of Grafted Cells: Can the Transplant of Younger Stem Cells Be Exploited To Rejuvenate Hematopoiesis?.

Alberto Rocci, MD, Marco Ruella, MD, Irene Ricca, MD, Cristiana Carniti, PhD, Manuela Zanni, MD, Chiara Lobetti Bodoni, MD, Marco Ladetto, MD, Daniele Caracciolo, MD, Mario Boccadoro, MD, Paolo Corradini, MD, Corrado Tarella, MD

Blood (2007) 110 (11): 3025.

https://doi.org/10.1182/blood.V110.11.3025.3025

Published: 2007

NARROW

The Genomic and Transcriptomic Landscape of Double-Refractory Multiple Myeloma

Timing the Initiation of Multiple Myeloma

Dose-Adjusted EPOCH and Rituximab (DA-EPOCH-R) Treatment in Dual Expressor Diffuse Large B-Cell and Double/Triple Hit Lymphomas: TP53 Mutations Influence on Clinical Outcome

The Real Life Accessibility to CAR T-Cell Therapy: Current Experience in the Only Active Center in Italy

Role of Cell Source and Graft Composition in Haploidentical Transplantation Using Post-Transplant Cyclophosphamide

GATA-3 Expression in Peripheral T-Cell Lymphomas (PTCL): Identification of a Cut-Off and Prognostic Value in PTCL-NOS Versus Others Hystotypes

High Dose Chemotherapy with Autograft in First Relapse May Overcome the Poor Prognosis of Diffuse Large B-Cell Lymphoma Patients with MYC/BCL2 Co-Expression

Inhibition of Jak1/Jak2 Is More Effective Than Inhibition of Jak3 in Protecting Mice From Acute Graft-Versus-Host Disease (aGvHD) by Significantly Decreasing Alloreactive CD4+ T-Cells.

Evaluation of MRD Status by Flow Cytometry and PCR in Multiple Myeloma Elderly Patients Receiving Autologous Stem Cell Transplantation After Bortezomib-Supplemented Mobilization and Conditioning

G-CSF Stem Cell Mobilization Is Protective Against Acute Graft-Versus-Host Disease (aGvHD) by Increasing Myeloid-Derived Suppressor Cell (MDSC) Frequencies

High-Dose Rituximab in the Conditioning Regimen Before Allogeneic Stem Cell Transplantation Reduces the Incidence of Acute Gvhd in B-Cell Lymphomas

Noninvasive Prediction of Acute Graft-Verus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation by Circulating miRNA Profiling

Analysis of Circulating Microrna Expression Profile In Patients Transplanted From Matched Unrelated Donors (MUD) Identifies mir203 as a Putative Marker of aGVHD

Impact of Minor Histocompatibility Antigens (mHAg) Mismatches On Gvhd Incidence in Non-Myeloablative or Reduced Intensity Allogeneic Stem Cell Transplantation.

Donor Lymphocyte Infusions and Rituximab Are An Effective Treatment Strategy for B-Cell Lymphoma Relapsing After Reduced Intensity Allogeneic Stem Cell Transplantation.

CD8-Depleted Donor Lymphocyte Infusions Can Improve Both T- and B-Cell Reconstitution after Allogeneic Stem Cell Transplantation from Haploidentical Family Donors

Long-Term Follow-up of Patients Affected by Relapsed Lymphomas Receiving Reduced-Intensity Conditioning (RIC) Regimen Followed by Allogeneic Stem Cell Transplantation (Allo-SCT): An Update of the Phase II Study of the Gruppo Italiano Trapianto Di Midollo Osseo (GITMO)

Qualitative and Quantitative PCR Monitoring of MRD: Practical Implications of a Surrogate Marker for GVL Effect after RIC Allogeneic Transplantation in Relapsed Chronic Lymphocytic Leukemia.

Telomere Length of Hematopoietic Cells Following Autologous and Allogeneic Stem Cell Transplant (SCT) Reflects That of Grafted Cells: Can the Transplant of Younger Stem Cells Be Exploited To Rejuvenate Hematopoiesis?.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only